Brief: Zim Laboratories Says Not Received Any Show-Cause Notice Or Any Notice To Stop Manufacturing From Any Drug Authority
21/04/2023 13:13
April 21 (Reuters) - Zim Laboratories Ltd ZIML.NS :
* NOT RECEIVED ANY SHOW-CAUSE NOTICE OR ANY NOTICE TO STOP
MANUFACTURING FROM ANY DRUG AUTHORITY
Source text for Eikon: ID:nNSE97BDRC
Further company coverage: ZIML.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zim Laboratories
See all newsBrief: Zim Laboratories Gets Marketing Authorization For Dabigatran Etexilate Capsules In Italy, Europe
Brief: Zim Laboratories March-Quarter Consol Net Profit 37.4 Mln Rupees
Brief: Zim Laboratories To Consider Fund Raising Via Securities Issuance
Brief: Zim Laboratories Gets Marketing Authorization For Tamsulosin + Dutasteride Capsules In Australia
India's Zim Laboratories up after getting marketing authorization for migraine drug in Australia